| 1.1 Relief of overall pain ‐ dichotomous ‐ decrease of pain |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 1.1.1 Decreases in pelvic pain scores ‐ 3 months |
1 |
87 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.14 [1.41, 3.24] |
| 1.1.2 Decreases in dysmenorrhoea scores ‐ 3 months |
1 |
85 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.25 [1.59, 3.16] |
| 1.1.3 Decreases in dyspareunia scores ‐ 3 months |
1 |
59 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.21 [1.39, 3.54] |
| 1.1.4 Decreases in pelvic tenderness scores ‐ 3 months |
1 |
85 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.28 [1.48, 3.50] |
| 1.1.5 Decreases in pelvic induration scores ‐ 3 months |
1 |
81 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.07 [0.64, 1.79] |
| 1.2 Adverse effects ‐ dichotomous |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 1.2.1 Hot flushes/flashes ‐ 3 months |
1 |
100 |
Risk Ratio (M‐H, Fixed, 95% CI) |
3.08 [1.89, 5.01] |
